Haloperidol Injection, Solution
Product Images NDC 63323-474

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Haloperidol (NDC 63323-474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hal08 0004 01

This text is a chemical formula and does not provide enough information to generate a useful description.*

FDA Label Image

Hal08 0004 02

FDA Label Image

Hal08 0004 03

This is a description of Haloperidol, an injection medication produced by pharmaceutical company Fresenius Kabi. The National Drug Code number is 63323-474-00 and the medication comes in a 1mL single dose vial for intramuscular use only. It is a sterile medication that should be protected from light. The medication is for immediate release and is available only with a prescription. Lot/exp numbers are also provided.*

FDA Label Image

Hal08 0004 04

This is a prescription drug called Haloperidol, available in 25 single dose vials for intramuscular use. It contains 5 mg/ml haloperidol (as the lactate) with other ingredients such as lactic acid for pH adjustment, methylparaben, and propylparaben. The container closure is not made with natural rubber latex. It is manufactured by Fresenius Kabi in Lake Zurich, IL, and should be stored at 20° to 25°C (68° to T7°F) [see USP Controlled Room Temperature] and protected from light. The dosage information should be consulted on the package insert.*

FDA Label Image

Hal08 0004 05

This is a medication with NDC code 63323-474-10 and Lot/Exp 401936. It is a Haloperidol injection solution containing 5mg Haloperidol (as the lactate), methylparaben, propylparaben, and lactic acid. The typical dosage should be consulted from the package insert. It is to be stored at a temperature of 20°C to 25°C and protected from light. The drug is in a 10ml multiple-dose vial and should not be frozen.*

FDA Label Image

Hal08 0004 06

This is a description for a medication called Haloperidol Injection, USP. Each 10 mL vial contains 50 mg per 10 mL (5 mg per mL). The injection is for immediate release and is intended for intramuscular use. It includes 5 mg haloperidol (as the lactate); with 1.8 mg methylparaben, 0.2mg propylparaben and lactic acid for pH adjustment between 3.0 to 3.8. The usual dosage information can be found in the package insert. It should be stored at 20° to 25°C (68° to 77°F) and protected from light. The container closure is not made with natural rubber latex.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.